Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Preferred Equity

Arcus Biosciences Inc Preferred Equity Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Preferred Equity from 2017 to 2017.
  • Arcus Biosciences Inc Preferred Equity for the quarter ending December 12, 2017 was $226m
  • Arcus Biosciences Inc Preferred Equity for the last 12 months ending December 12, 2017 was $226m
  • Arcus Biosciences Inc Annual Preferred Equity for 2017 was $226m a 47.19% increase of 107m from 2016
  • Arcus Biosciences Inc Annual Preferred Equity for 2016 was $119m
Other Balance Sheet Metrics:
  • Arcus Biosciences Inc Total Assets for the quarter ending December 12, 2018 was $275m a -11.08% decrease of -30m year over year
  • Arcus Biosciences Inc Other Liabilities for the quarter ending December 12, 2018 was $23m a -6.50% decrease of -1m year over year
  • Arcus Biosciences Inc Total Equity for the quarter ending December 12, 2018 was $235m a -13.47% decrease of -32m year over year
View Chart On Koyfin

Quarterly RCUS Preferred Equity Data

12/2017$226m
03/2017$119m

Annual RCUS Preferred Equity Data

2017$226m
2016$119m